$ABC (AmerisourceBergen Corporation)

$ABC {{ '2016-05-05T14:22:10+0000' | timeago}} • Announcement

$ABC said it cut its FY16 adjusted EPS outlook to $5.44 to $5.54 from prior expectations of $5.73 to $5.83 due to an increase in the rate of generic deflation, and a lower contribution from new generic launches. The company preliminarily expects FY2017 adjusted EPS growth to in the range of 4% to 6%.

$ABC {{ '2018-01-03T14:03:33+0000' | timeago}} • Announcement

$ABC completed the acquisition of H. D. Smith, the largest independent wholesaler in the U.S., for $815MM in cash. The acquisition is designed to enhance and expand the company's strategic scale, strengthen its support to community pharmacy and drive long-term, durable value.

$ABC {{ '2017-11-30T19:58:54+0000' | timeago}} • Announcement

$ABC priced $750MM aggregate principal amount of its 3.45% Senior Notes due December 15, 2027 and $500MM aggregate principal amount of its 4.30% Senior Notes due December 15, 2047, in an underwritten registered public offering.

$ABC {{ '2017-11-02T18:31:56+0000' | timeago}} • Infographic

$ABC AmerisourceBergen Earnings AlphaGraphic: Q4 2017 Highlights

$ABC {{ '2017-08-10T14:57:42+0000' | timeago}} • Announcement

Pharmaceuticals company $ABC declared a quarterly dividend of $0.365 per share on its common shares. The dividend is payable on September 5, 2017, to stockholders of record on August 21, 2017.

$ABC {{ '2017-06-19T13:57:06+0000' | timeago}} • Announcement

$ABC has adopted a new organizational structure designed to further align it to customer needs in a more unified way, while accelerating growth. AmerisourceBergen’s customer-facing offerings will now be aligned under two groups named Pharmaceutical Distribution and Strategic Global Sourcing and Global Commercialization Services and Animal Health.

$ABC {{ '2017-06-19T12:46:58+0000' | timeago}} • Announcement

$ABC announced a new organizational structure. Commercialization Services and Animal Health will be led by Group President James Cleary, Jr., and includes the company's solutions for product commercialization and patient access, as well as international development and animal health.

$ABC {{ '2017-06-19T12:46:20+0000' | timeago}} • Announcement

$ABC announced a new organizational structure. Pharmaceutical Distribution and Strategic Global Sourcing will be led by Group President Robert Mauch. Peyton Howell will assume a new role as President, Health Systems, Physician Practices and Strategic Health Solutions.

$ABC {{ '2017-05-09T12:31:10+0000' | timeago}} • Announcement

The Board of Directors of $ABC declared a quarterly dividend of $0.365 per common share, payable June 5, 2017, to stockholders of record on May 22, 2017.

$ABC {{ '2017-05-04T19:49:40+0000' | timeago}} • Webcast

$ABC said that the expected seasonality in the business due to the holidays affected the FY17 free cash flow guidance, as it sees modest levels in 3Q17 and then up in 4Q17.

$ABC {{ '2017-05-04T19:44:50+0000' | timeago}} • Webcast

$ABC plans to start servicing Prime Alliance JV, which is mainly specialty products, next month. The company does not expect it to have an impact on FY17 but sees its benefit going forward in FY18.

$ABC {{ '2017-05-04T11:05:28+0000' | timeago}} • Announcement

$ABC continues to operate under the following working assumptions regarding the pharmaceutical market into its FY17 expectations. $ABC sees brand drug inflation of 7-9%, generic drug deflation of down 7-9%, contributions from new generic launches similar to the prior year and no significant contributions from biosimilars.

$ABC {{ '2017-05-04T11:02:33+0000' | timeago}} • Announcement

$ABC lowered its 2017 revenue growth outlook to 5.5-6.5% from 6.5-8% and adjusted operating expense growth estimate to 2-3% from 4.5-6%. The company narrowed its 2017 adjusted EPS guidance to $5.77-5.92 from $5.72-5.92 and adjusted operating income forecast to flat-to-up 2% from flat-to-up 4%.

$ABC {{ '2017-05-04T11:02:12+0000' | timeago}} • Announcement

$ABC reported a 31.8% drop in 2Q17 earnings due to last year's warrants income. Net income fell to $411.47MM or $1.86 per share from $603.45MM or $2.68 per share last year. Revenue rose 4.1% to $37.15Bil, on higher Pharmaceutical Distribution Services revenue and a rise in Other revenue. Adjusted EPS increased to $1.77 from $1.68.

$ABC {{ '2017-05-01T12:43:49+0000' | timeago}} • Announcement

$ABC has signed a new five-year agreement to supply pharmaceuticals to $ESRX. The agreement extends through September 30, 2022. AmerisourceBergen and Express Scripts’ most recent supply deal began in October 2012 and was set to expire in September 2017. The fiscal year 2016 revenue contribution from that agreement was approx $23Bil.

$ABC {{ '2017-05-01T12:40:25+0000' | timeago}} • Announcement

$ABC signed a new 5-year agreement to supply pharmaceuticals to $ESRX. The agreement extends through Sept. 30, 2022. $ABC and $ESRX most recent supply agreement began in October 2012 and was set to expire in September 2017. The FY16 revenue contribution from that agreement was about $23Bil.

$ABC {{ '2017-02-09T16:37:51+0000' | timeago}} • Announcement

$ABC's BoD declared a quarterly dividend of $0.365 per common share. The dividend is payable on March 6, 2017, to stockholders of record at the close of business on Feb. 21, 2017.

$ABC {{ '2017-01-31T18:00:21+0000' | timeago}} • Webcast

For FY17, $ABC revised OpEx growth rate to 4.5-6.0%. The company expects that expenses will increase to support the revenue ramp. $ABC started to incur incremental costs related to several IT and infrastructure investments. Operating income dollar growth to be flat to up 4% vs. FY16. $ABC expects modest share repurchase activity in the near term.

$ABC {{ '2017-01-31T17:47:41+0000' | timeago}} • Webcast

For FY17, $ABC expects US pharmaceutical sector to grow, driven by patient demographics as strengthening US economy and a robust pipeline of new brand drug launches. The company is building the new state-of-the-art distribution centers, which are expected to be fully online by the end of FY17.

$ABC {{ '2017-01-31T12:13:38+0000' | timeago}} • Announcement

$ABC is updating its outlook for FY17. $ABC expects its revenues to be approx. 6.5-8% growth over FY16. The company raised its adjusted diluted EPS from the previous guidance of $5.63-5.88 to $5.72-5.92, reflecting growth of 2-5% compared to FY16.

$ABC {{ '2017-01-31T12:10:03+0000' | timeago}} • Announcement

During 1Q17, $ABC's revenue from its Pharmaceutical Distribution revenue rose 3.9% to $36.6Bil compared to 1Q16. This increase was mainly due to organic sales growth. The segments operating income was down 1.9% to $374MM. Revenue in Other rose 5.4% YoverY during the quarter to $1.7Bil. Operating income in Other rose 17.4% to $112MM.

Recent Transcripts

PDCO (Patterson Companies, Inc.)
Tuesday, November 21 2017 - 3:00pm
BTX (BioTime, Inc.)
Thursday, November 9 2017 - 9:30pm
HSIC (Henry Schein, Inc.)
Monday, November 6 2017 - 3:00pm
CAH (Cardinal Health, Inc.)
Monday, November 6 2017 - 1:30pm
HLF (Herbalife Ltd.)
Thursday, November 2 2017 - 9:30pm
HSKA (Heska Corporation)
Thursday, November 2 2017 - 3:00pm
ABC (AmerisourceBergen Corporation)
Thursday, November 2 2017 - 12:30pm
TEVA (Teva Pharmaceutical Industries Limited)
Thursday, November 2 2017 - 12:00pm
NUS (Nu Skin Enterprises Inc.)
Wednesday, November 1 2017 - 9:00pm
AGN (Allergan plc)
Wednesday, November 1 2017 - 12:30pm
IDXX (IDEXX Laboratories, Inc.)
Tuesday, October 31 2017 - 12:30pm
ABBV (AbbVie Inc.)
Friday, October 27 2017 - 1:00pm
MCK (McKesson Corporation)
Thursday, October 26 2017 - 12:00pm
TSCO (Tractor Supply Company)
Wednesday, October 25 2017 - 9:00pm
BAX (Baxter International Inc.)
Wednesday, October 25 2017 - 12:30pm
ABAX (Abaxis, Inc.)
Tuesday, October 24 2017 - 8:15pm
UNH (UnitedHealth Group Incorporated)
Tuesday, October 17 2017 - 12:45pm
PDCO (Patterson Companies, Inc.)
Thursday, August 24 2017 - 2:00pm
AMS (American Shared Hospital Services)
Thursday, August 10 2017 - 7:00pm
HSIC (Henry Schein, Inc.)
Tuesday, August 8 2017 - 2:00pm

AlphaGraphics you may like